Kaloba (Pelargonium Sidoides Root Liquid Extraction Preparation (1 : 8-10), Extraction Solvent: Ethanol 11 %)

Pelargonium sidoides root extract is believed to modulate the immune response by activating macrophages and stimulating cytokine release. It may also improve mucociliary clearance and exhibit mild antimicrobial activity, helping the body clear respiratory pathogens and reduce cough.

The appropriate dose of Kaloba is determined by a qualified healthcare professional based on the patient’s age, weight and clinical condition. Prescribers typically advise a measured amount using the provided dosing device, and the regimen may be adjusted as needed.

Safety data for Kaloba in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their physician before using the product.

To order Kaloba, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Standard cough syrups often contain dextromethorphan or codeine, which act centrally to suppress cough. Kaloba uses a herbal extract that supports the body’s innate immune response and mucociliary function, offering a symptomatic relief approach without central nervous system depression.

Kaloba should be stored at ambient temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Kaloba is taken orally. The liquid is measured with the supplied dosing device and swallowed directly. It can be taken with or without food, according to the prescriber’s instructions.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, serious skin disorders like Stevens‑Johnson syndrome, and potential liver injury. Patients should seek immediate medical attention if they notice signs of a severe reaction.

Kaloba should be avoided by individuals with a known hypersensitivity to Pelargonium species, children under two years of age unless advised by a physician, and patients taking strong immunosuppressive therapy without medical supervision.